Aktis Oncology, Inc.
$25.78
-0.40 (-1.53%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +12.1%
- 3 Months
- +24.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Jan 2026
- -32.2%
Own AKTS?
See how AKTS contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.